Oral Bisphosphonate Did Not Improve Prognosis For Patients With Breast Cancer
Results from a German study demonstrated no improvement in disease-free survival among patients with breast cancer who were treated with dose-dense chemotherapy and the bisphosphonate ibandronate. Volker Möbus, Ph.D...